• LAST PRICE
    18.3700
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.0000/ 0
  • Ask / Lots
    20.5000/ 1
  • Open / Previous Close
    18.0100 / 18.3700
  • Day Range
    Low 17.7900
    High 18.9350
  • 52 Week Range
    Low 12.6700
    High 93.9800
  • Volume
    128,097
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 18.03
TimeVolumeIGMS
09:32 ET88018.01
09:38 ET10017.79
09:41 ET10018.275
09:45 ET20018.92
09:48 ET24918.8988
09:52 ET40018.8
09:54 ET10018.925
09:56 ET50018.87
09:57 ET30018.935
09:59 ET10018.75
10:01 ET20018.81
10:06 ET80018.675
10:08 ET10018.6488
10:10 ET45518.7225
10:12 ET92618.63
10:14 ET89918.62
10:19 ET73018.7
10:24 ET20018.77
10:26 ET20018.54
10:28 ET10018.5
10:30 ET21318.43
10:32 ET10018.43
10:33 ET50018.64
10:35 ET50018.535
10:39 ET50018.455
10:42 ET10018.38
10:44 ET11518.41
10:46 ET50618.4
10:51 ET30018.42
10:57 ET70018.51
11:00 ET20018.475
11:04 ET40018.34
11:06 ET109618.36
11:09 ET40018.46
11:11 ET100018.46
11:13 ET30018.48
11:15 ET36018.5
11:18 ET55018.5
11:20 ET452318.55
11:22 ET140018.61
11:24 ET10018.6
11:26 ET20018.59
11:31 ET40018.7
11:33 ET21018.62
11:36 ET60018.635
11:40 ET81618.535
11:42 ET10018.52
11:45 ET10018.435
11:49 ET24218.37
11:51 ET10018.31
11:58 ET10018.265
12:02 ET10018.21
12:03 ET30018.16
12:16 ET10018.24
12:18 ET30018.28
12:20 ET20018.34
12:21 ET10018.37
12:25 ET10018.34
12:27 ET10018.34
12:30 ET10018.38
12:36 ET10018.26
12:39 ET30018.18
12:41 ET40018.25
12:48 ET30018.155
12:56 ET10018.145
12:57 ET41718.12
12:59 ET10018.09
01:06 ET237617.8505
01:10 ET10017.865
01:14 ET10017.96
01:15 ET10017.99
01:17 ET10017.95
01:21 ET20018.02
01:32 ET30018.16
01:33 ET10018.2
01:37 ET20018.21
01:42 ET20018.17
01:48 ET30018.22
01:51 ET10018.3
01:53 ET30018.14
01:57 ET10018.23
02:02 ET10018.23
02:04 ET20018.21
02:08 ET20018.19
02:09 ET40018.19
02:13 ET32418.21
02:15 ET10018.33
02:18 ET80018.245
02:20 ET64118.21
02:24 ET10018.27
02:26 ET70018.37
02:38 ET10018.41
02:40 ET10018.38
02:42 ET50018.48
02:44 ET30018.52
02:54 ET204618.48
02:56 ET24718.38
03:00 ET133418.4
03:14 ET10018.455
03:18 ET10018.43
03:20 ET10018.43
03:25 ET10018.43
03:27 ET20018.375
03:30 ET40018.4068
03:32 ET10018.46
03:34 ET52218.4679
03:36 ET148118.375
03:39 ET72418.39
03:43 ET10018.385
03:45 ET90018.36
03:50 ET30018.43
03:52 ET124018.36
03:54 ET47018.36
03:56 ET30718.39
03:57 ET193918.35
03:59 ET333718.37
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIGMS
IGM Biosciences Inc
781.2M
-3.3x
---
United StatesDSGN
Design Therapeutics Inc
786.0M
-18.0x
---
United StatesCINC
CinCor Pharma Inc
768.5M
-11.8x
---
United StatesNUVB
Nuvation Bio Inc
767.8M
-8.4x
---
United StatesAVXL
Anavex Life Sciences Corp
797.3M
-17.8x
---
United StatesVERV
Verve Therapeutics Inc
760.6M
-5.5x
---
As of 2022-07-05

Company Information

IGM Biosciences, Inc. is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The Company has created an IgM antibody technology platform for developing T cell engagers, receptor cross-linking agonists, targeted cytokines and target neutralizers. Its product candidates in clinical testing include IGM-2323 and IGM-8444. IGM-2323 is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 proteins, is in a Phase II clinical trial for the treatment of relapsed/refractory B cell non-Hodgkins lymphoma (NHL) patients. IGM-8444 is an IgM antibody targeting Death Receptor 5 (DR5) proteins for the treatment of patients with solid and hematologic malignancies, is in a Phase I clinical trial for the treatment of solid cancers. Its oncology pipeline also includes IGM-7354, IGM-2644 and IGM-2537.

Contact Information

Headquarters
325 E Middlefield RdMOUNTAIN VIEW, CA, United States 94043-4003
Phone
650-965-7873
Fax
302-655-5049

Executives

Independent Chairman of the Board
Michael Loberg
President, Chief Executive Officer, Director
Fred Schwarzer
Chief Financial Officer
Misbah Tahir
Chief Scientific Officer
Bruce Keyt
Chief Business Officer
Lisa Decker

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$781.2M
Revenue (TTM)
$0.00
Shares Outstanding
42.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-5.51
Book Value
$7.54
P/E Ratio
-3.3x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.